Naya Biosciences Inc.
13F holders, Q4 2024 (December 31)9holders −3
0new positions
4sold out
$0.81avg. 13F price*
At the end of Q4 2024, 9 institutions reported holding Naya Biosciences Inc. in their 13F filings, down 3 from Q3 2024. 0 opened new positions and 4 sold out. The largest holders were CWC Advisors, LLC. ($81K), Vanguard Group Inc. ($44K) and Geode Capital Management, LLC ($28K).
- Company
- Naya Biosciences Inc.
- CUSIP
- 44984F401
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 4 | $48K |
All 13F filers, Q3 2024 → Q4 2024: 251 shares bought and 69,943 shares sold, net −69,692 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| CWC Advisors, LLC. | 0.08% | No change | 100,477 | $81K |
| Vanguard Group Inc. | 0.00% | No change | 54,058 | $44K |
| Geode Capital Management, LLC | 0.00% | Reduce -0.7% | 34,956 | $28K |
| UBS Group AG | 0.00% | Reduce -9.7% | 10,250 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -23.6% | 3,897 | $3K |
| Osaic Holdings, Inc. | 0.00% | Add +100.0% | 500 | $405 |
| Bank of America Corp. | 0.00% | Add +3.2% | 32 | $26 |
| SBI Securities Co., Ltd. | 0.00% | — | 5 | $4 |
| Gleason Group, Inc. | 0.00% | No change | 3 | $2 |
"% of holder's portfolio" is NAYA BIOSCIENCES INC's weight in each manager's 13F, not the share of Naya Biosciences Inc. the manager owns.